ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Eyenovia Inc

Eyenovia Inc (EYEN)

0.0853
-0.0047
(-5.22%)
Cerrado 21 Diciembre 3:00PM
0.0868
0.0015
(1.76%)
Fuera de horario: 6:58PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.0868
Postura de Compra
0.0862
Postura de Venta
0.0889
Volume Operado de la Acción
14,362,319
0.0831 Rango del Día 0.0948
0.077 Rango de 52 semanas 2.57
Capitalización de Mercado [m]
Precio Anterior
0.09
Precio de Apertura
0.0831
Última hora de negociación
Volumen financiero
US$ 1,272,947
Precio Promedio Ponderado
0.088631
Volumen promedio (3 m)
8,917,704
Acciones en circulación
86,441,611
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.29
Beneficio por acción (BPA)
-0.32
turnover
4k
Beneficio neto
-27.26M

Acerca de Eyenovia Inc

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precis... Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Wilmington, Delaware, USA
Fundado
-
Eyenovia Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEN. The last closing price for Eyenovia was US$0.09. Over the last year, Eyenovia shares have traded in a share price range of US$ 0.077 to US$ 2.57.

Eyenovia currently has 86,441,611 shares in issue. The market capitalisation of Eyenovia is US$7.78 million. Eyenovia has a price to earnings ratio (PE ratio) of -0.29.

EYEN Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.00425.084745762710.08260.09350.077185282470.08709207CS
4-0.0245-22.01257861640.11130.12930.077182761520.09508566CS
12-0.3532-80.27272727270.440.59160.07789177040.12320988CS
26-0.5532-86.43750.641.560.07750078500.22698166CS
52-1.6732-95.06818181821.762.570.07730160530.38088485CS
156-3.7632-97.74545454553.855.850.07711743010.68368921CS
260-3.5732-97.62841530053.667.720.0778245271.28938921CS

EYEN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Eyenovia?
El precio actual de las acciones de Eyenovia es US$ 0.0868
¿Cuántas acciones de Eyenovia están en circulación?
Eyenovia tiene 86,441,611 acciones en circulación
¿Cuál es la capitalización de mercado de Eyenovia?
La capitalización de mercado de Eyenovia es USD 7.78M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Eyenovia?
Eyenovia ha negociado en un rango de US$ 0.077 a US$ 2.57 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Eyenovia?
El ratio precio/beneficio de Eyenovia es -0.29
¿Cuál es la moneda de reporte de Eyenovia?
Eyenovia presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Eyenovia?
El último ingresos anual de Eyenovia es USD 4k
¿Cuál es el último beneficio anual de Eyenovia?
El último beneficio anual de Eyenovia es USD -27.26M
¿Cuál es la dirección registrada de Eyenovia?
La dirección registrada de Eyenovia es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Eyenovia?
La dirección del sitio web de Eyenovia es www.eyenoviabio.com
¿En qué sector industrial opera Eyenovia?
Eyenovia opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

EYEN Discussion

Ver más
hondaboost hondaboost 4 semanas hace
Scam: selling 24 Million new shares at $0.10 , just before probable "Bankruptcy"!

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform, today announced that it has entered into a securities purchase agreement with a healthcare focused institutional investor for the purchase and sale of 12,081,785 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 24,163,570 shares of common stock in a registered direct offering at a combined offering price of $0.1076 per share and accompanying warrants. T
👍️0
glenn1919 glenn1919 4 semanas hace
EYEN..............................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
RC_702 RC_702 2 meses hace
And then again, maybe not. You still up 200% or did you sell during that balloon ride
👍️0
saigai saigai 3 meses hace
still holding.. see you at trips
👍️0
saigai saigai 3 meses hace
just going to hold i dont care anymore im tired of wishing on a star..im better off spending my days with the prayer beads than this nonsense
👍️0
saigai saigai 3 meses hace
eyen 3200 at .59 lets gooo
👍️0
rosemountbomber rosemountbomber 4 meses hace
Have to agree with you. I was surprised at the size of this offering. Rather not go through this again so will lighten up or liquidate completely on the next strong upward move.
👍️0
ProLiberty ProLiberty 4 meses hace
It cost the company a 40% decline and dilution at $0.40 in exchange for 2.5 months of added runway. Not long ago they raised another $5m from 2 investors at $0.62 + warrants (also dilutive). They hope Oct data will allow accelerated approval of Micropine but even if good and accelerated still 12 months from approval. They will still burn and need to raise multiple times between now and 12 months from now. Perhaps they will be able to do it at a higher stock price if the Oct data is good but unclear. To buy today you need to be very confident that Oct data will be excellent.
👍️0
Monksdream Monksdream 4 meses hace
EYEN new 52 low
👍️0
govprs govprs 4 meses hace
I added. Great buy the dip opportunity
👍️0
rosemountbomber rosemountbomber 4 meses hace
Well the good thing arrived this morning. 13 million share dilution:

https://finance.yahoo.com/news/eyenovia-announces-pricing-5-14-132900005.html
👍️0
Southern Gal Southern Gal 5 meses hace
Another good day. I'm up 93.15% in 2 months time.

Typically, when an insider loads up, good thing are coming.
👍️ 1
rosemountbomber rosemountbomber 5 meses hace
Thanks. Info 20 days late
👍️ 1
glenn1919 glenn1919 5 meses hace
EYEN............................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
Southern Gal Southern Gal 5 meses hace
INSIDER BUYS $660,000 WORTH OF EYEN
Name: GRANT STUART M
Symbol Date Shares Proceeds Transaction Details
EYEN 2024-07-02 1.515M $1,000,000.00 Purchase at $0.66 per share.

https://benchwalk.com/bench-walk-advisors-llc-litigation-financing-experts-team/stuart-grant-co-founder-managing-director
👍️0
Monksdream Monksdream 5 meses hace
EYEN under $2
👍️0
Southern Gal Southern Gal 5 meses hace
Wow!! Another BIG up day

$1.18

+$0.11
+10.28%
👍️0
Southern Gal Southern Gal 5 meses hace
Well- I got my $1. Looking for more
👍️0
Southern Gal Southern Gal 7 meses hace
Picked up more today.
Time will tell...
👍️0
Southern Gal Southern Gal 7 meses hace
I started buying today. Looking for $1
👍️0
Dennis14 Dennis14 8 meses hace
I bought in today. Now I’ll sit and wait.
👍️0
Monksdream Monksdream 8 meses hace
EYEN new 52 lo
👍️0
Monksdream Monksdream 8 meses hace
EYEN new 52 lo
👍️0
Monksdream Monksdream 9 meses hace
EYEN under $2
👍️0
Monksdream Monksdream 9 meses hace
EYEN under $2
👍️0
glenn1919 glenn1919 10 meses hace
EYEN..........................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 meses hace
EYEN.......................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 meses hace
EYEN under $2
👍️0
Monksdream Monksdream 1 año hace
EYEN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
EYEN new 52 week low
👍️0
Monksdream Monksdream 1 año hace
EYEN under $2
👍️0
honest dave honest dave 3 años hace
EYEN --
--Northland Adjusts Eyenovia's Price Target to $9 From $12, Maintains Outperform Rating
BY MT Newswires
— 9:31 AM ET 10/26/2021
👍️0
jdlamont jdlamont 4 años hace
EYEN now trading options!!!!
👍️0
jdlamont jdlamont 4 años hace
EYEN now trading options!!!!
👍️0
beambe beambe 4 años hace
Good NEWS
👍️0
beambe beambe 4 años hace
good Volume
👍️0
beambe beambe 4 años hace
https://eyenovia.com/about-2019/

👍️0
ClayTrader ClayTrader 4 años hace
* * $EYEN Video Chart 08-11-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
beambe beambe 4 años hace
good Volume
👍️0
breezy1 breezy1 4 años hace
OCGN - .62 orphan FDA approvals
👍️0
crudeoil24 crudeoil24 4 años hace
Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea
8:05 am ET August 11, 2020 (Globe Newswire) Print
Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones and Development Costs

Arctic Vision to Lead Expansion of Novel Approach to Treating Myopia and Presbyopia in Greater China and South Korea

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP(TM)) therapeutics and Arctic Vision, a clinical stage biotech company focused on developing and commercializing innovative ophthalmology therapies in China and Asia, today announced that they have entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Under the terms of the agreement, Eyenovia may receive up to a total of $45.75 million in upfront payments as well as additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs. In addition, Arctic Vision will purchase its supply of MicroPine and MicroLine from Eyenovia or, for such products not supplied by Eyenovia, pay Eyenovia a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. Eyenovia will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to its Asian licensee pursuant to the arrangement
👍️0
BioSpecialist BioSpecialist 5 años hace
next $10 stock soon
👍️0
BioSpecialist BioSpecialist 5 años hace
STRONG BUY
👍️0
BioSpecialist BioSpecialist 5 años hace
EYEN = MC $60 Million /NDA submission for BIG drug in Q3 / 2 more Drugs in Phase 3 including a potential Blockbuster /Undiscovered low float gem = A Potential 10+ Bagger Gem ..GLTA



👍️0
jdlamont jdlamont 5 años hace
anyone who sees the video of the kid using the machine will buy the stock.
So easy and simple to use-REVOLUTIONARY. Very impressive.
👍️0
ADVFN_bioking ADVFN_bioking 5 años hace
RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
👍️0
ADVFN_bioking ADVFN_bioking 5 años hace
looks like next breakout about to start
👍️0
ADVFN_bioking ADVFN_bioking 5 años hace
Load up before she takes off again
👍️0
ADVFN_bioking ADVFN_bioking 5 años hace
STRONG BUY this pure undiscovered Goldmine
👍️0
JGCola JGCola 5 años hace
Down a lot today. I'd say related to ALDX (another "eyes" biotech) which is down about 32% following Top-Line results. It's a mistake to associate the faith of those 2 IMO. This is creating a great opportunity. Will go back over 4$ very soon and may never "look" back. This wild horse will suddenly run free at some point. Great MGT. Founder keeps on buying. Great innovation. First-in-class comes to mind.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock